A major user of the technology is expected to be DNA testing laboratories, which hope to translate patient-specific genetic characterization to patient-specific clinical treatment advice for molecular diseases.
Doctor of Medicine | Medicine | medicine | Nobel Prize in Physiology or Medicine | Physical medicine and rehabilitation | New York University School of Medicine | Baylor College of Medicine | Washington University School of Medicine | Strong Medicine | Stanford University School of Medicine | Royal Society of Medicine | Old Crow Medicine Show | Nuclear medicine | molecular biology | Albert Einstein College of Medicine | School of Medicine | Molecular Biology | Internal medicine | Institute of Medicine | Indiana University School of Medicine | Dr. Quinn, Medicine Woman | traditional Chinese medicine | London School of Hygiene & Tropical Medicine | Internal Medicine | Tufts University School of Medicine | Pritzker School of Medicine | Osteopathic medicine in the United States | Molecular biology | Bachelor of Medicine, Bachelor of Surgery | alternative medicine |
Giulio Superti-Furga Scientific Director of the Research Center for Molecular Medicine of the Austrian Academy of Sciences
Instituto de Medicina Molecular (Institute of Molecular Medicine), a research institution of the University of Lisbon, in Lisbon, Portugal.
Journal of Cellular and Molecular Medicine (abbreviated J Cell Mol Med or JCMM) is a bi-monthly, peer-reviewed, scientific journal published by Wiley-Blackwell in association with the Foundation for Cellular and Molecular Medicine.
Richard Béliveau (born 1953 in Trois-Rivières, Quebec) is currently the director of the Molecular Medicine Laboratory and a researcher in the Department of Neurosurgery at Notre-Dame Hospital.
In 2009, Sequenom Center for Molecular Medicine (SCMM) was expected to launch the SEQureDx prenatal screening tests for Down syndrome and Rhesus D. Subsequent investigation revealed significant flaws in the studies of the test's effectiveness.
MaterniT21 PLUS is Sequenom Center for Molecular Medicine's prenatal test for trisomy 21 Down syndrome, trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome).
In 2009, the Center for Molecular Medicine of Karolinska University Hospital and Tianjin Medical University announced an agreement to build the Sino-Swedish Center for Molecular Medicine.